ScholarIQanswers from OpenAlex

Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer

PaperCitations, authors & open-access status

Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer have?

ScholarIQcitation count

Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer has 18 citations in the OpenAlex counts ScholarIQ stores.

When was Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer published?

ScholarIQyear

Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer has 2025 year in the ScholarIQ index.

What is the open-access status of Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer?

ScholarIQoa status

Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer has gold oa status in the ScholarIQ index.

What is the DOI of Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer?

ScholarIQdoi

The DOI for Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer is on the source record.

What is the PMID of Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer?

ScholarIQpmid

The PMID for Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer is on the source record.

What is the OpenAlex record for Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer?

ScholarIQopenalex

The OpenAlex for Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial